Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure.

[1]  J. Roos‐Hesselink,et al.  Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease , 2017, Circulation.

[2]  L. Burchill.  Heart transplantation in adult congenital heart disease , 2016, Heart.

[3]  O. Devine,et al.  Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010. , 2016, Circulation.

[4]  J. Roos‐Hesselink,et al.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. , 2016, European heart journal.

[5]  L. Iserin,et al.  Temporal trends and changing profile of adults with congenital heart disease undergoing heart transplantation. , 2016, European heart journal.

[6]  F. Meijboom,et al.  Heart transplantations in adults with congenital heart disease: new frontiers. , 2016, European heart journal.

[7]  K. Dimopoulos,et al.  Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association , 2016, Circulation.

[8]  K. Dimopoulos,et al.  Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[9]  W. Kraus,et al.  Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure. , 2016, Journal of the American College of Cardiology.

[10]  W. Budts,et al.  Patient-Reported Health in Young People With Congenital Heart Disease Transitioning to Adulthood. , 2015, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[11]  K. Dimopoulos,et al.  Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre , 2015, Circulation.

[12]  A. Moss,et al.  Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy. , 2015, Circulation. Heart failure.

[13]  W. Williams,et al.  Increasing mortality burden among adults with complex congenital heart disease. , 2015, Congenital heart disease.

[14]  P. Lambiase,et al.  Haemodynamic consequences of targeted single- and dual-site right ventricular pacing in adults with congenital heart disease undergoing surgical pulmonary valve replacement , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  A. Zwinderman,et al.  Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. , 2014, JACC. Heart failure.

[16]  Nandini Dendukuri,et al.  Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010 , 2014, Circulation.

[17]  G. Moe,et al.  Differences in the clinical characteristics of ethnic minority groups with heart failure managed in specialized heart failure clinics. , 2014, JACC. Heart failure.

[18]  G. Diller.  Chasing a moving target: outcome and risk stratification in patients with transposition of the great arteries after atrial switch operation. , 2014, European heart journal.

[19]  J. Langberg,et al.  Cardiac Resynchronization Therapy in Adult Patients with Repaired Tetralogy of Fallot and Left Ventricular Systolic Dysfunction , 2014, Pacing and clinical electrophysiology : PACE.

[20]  B. Deal,et al.  Heart transplantation for the failing Fontan. , 2013, The Annals of thoracic surgery.

[21]  A. Zwinderman,et al.  Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle. , 2013, Journal of the American College of Cardiology.

[22]  Piotr Ponikowski,et al.  EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.

[23]  A. Redington,et al.  Right ventricle: wrong targets? Another blow for pharmacotherapy in congenital heart diseases. , 2013, Circulation.

[24]  Nicholas Mitsakakis,et al.  A Population-Based Study to Evaluate the Effectiveness of Multidisciplinary Heart Failure Clinics and Identify Important Service Components , 2013, Circulation. Heart failure.

[25]  K. Dimopoulos,et al.  Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life--single centre experience and review of published data. , 2012, European heart journal.

[26]  R. McKelvie,et al.  Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction: Findings From the I-PRESERVE Trial , 2011, Circulation. Heart failure.

[27]  Jeroen J. Bax,et al.  Cardiac resynchronization therapy in paediatric and congenital heart disease patients. , 2011, European heart journal.

[28]  B. Kogon,et al.  Pulmonary arterial hypertension in patients with prior atrial switch procedure for d-transposition of great arteries (dTGA). , 2010, International journal of cardiology.

[29]  C. Irving,et al.  Cardiac transplantation in adults with congenital heart disease , 2010, Heart.

[30]  R. Ohye,et al.  A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. , 2010, The Journal of thoracic and cardiovascular surgery.

[31]  Constantinos Davos,et al.  Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease. , 2010, The American journal of cardiology.

[32]  J. Alejos,et al.  Pulmonary hypertension in patients after repair of transposition of the great arteries. , 2010, Congenital heart disease.

[33]  N. Best,et al.  Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease. , 2010, European heart journal.

[34]  P Engelfriet,et al.  Gender differences in adult congenital heart disease , 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[35]  A. Opotowsky,et al.  Trends in hospitalizations for adults with congenital heart disease in the U.S. , 2009, Journal of the American College of Cardiology.

[36]  D. Grobbee,et al.  Gender and Outcome in Adult Congenital Heart Disease , 2008, Circulation.

[37]  C. Phillips,et al.  Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. , 2007, Journal of the American College of Cardiology.

[38]  R. Lange,et al.  Presence of a Ventricular Septal Defect and the Mustard Operation Are Risk Factors for Late Mortality After the Atrial Switch Operation: Thirty Years of Follow-Up in 417 Patients at a Single Center , 2006, Circulation.

[39]  K. Norozi,et al.  Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. , 2006, The American journal of cardiology.

[40]  M. Cowie,et al.  Gender and heart failure: a population perspective , 2006, Heart.

[41]  J. Fleg,et al.  Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. , 2006, American heart journal.

[42]  P. Poole‐Wilson,et al.  Exercise Intolerance in Adult Congenital Heart Disease: Comparative Severity, Correlates, and Prognostic Implication , 2005, Circulation.

[43]  J. Girona,et al.  Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries , 2005, Heart.

[44]  J. Kautzner,et al.  Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. , 2004, Journal of the American College of Cardiology.

[45]  L. Fisher,et al.  Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) , 2003, Circulation.

[46]  C. Fraser,et al.  Outcome of 121 Patients with Congenitally Corrected Transpositionof the Great Arteries , 2002, Pediatric Cardiology.

[47]  J. Hoffman,et al.  Task force 1: the changing profile of congenital heart disease in adult life. , 2001, Journal of the American College of Cardiology.

[48]  I. Gessner,et al.  Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. , 2000, Journal of the American College of Cardiology.

[49]  P. Rizzon,et al.  Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. , 1994, European heart journal.

[50]  Y. Tabak,et al.  Burden of sodium abnormalities in patients hospitalized for heart failure. , 2011, Congestive heart failure.